Statistics for Safety and immunogenicity of an MF59 (R)-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
Total visits
| views | |
|---|---|
| Safety and immunogenicity of an MF59 (R)-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age | 82 |
Total visits per month
| views | |
|---|---|
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
File Visits
| views | |
|---|---|
| Safety and immunogenicity of an MF59 (R)-adjuvanted A H1N1 pandemic influenza vaccine in children from three to seventeen years of age.pdf | 5 |
Top country views
| views | |
|---|---|
| United States | 44 |
| Chile | 25 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 20 |
| Alameda | 5 |
| Concepcion | 5 |
| Campbell | 1 |
| Sacramento | 1 |
| Zapopan | 1 |